Why the study?
Does Angiotensin II induce IRS-1 degradation and impair insulin signaling in vascular smooth muscle cells?
Population
Vascular smooth muscle cells (VSMCs)
Comparison
Angiotensin II (100 nmol/L for 18 hours) vs Untreated control (implied)
Design
Preclinical
Follow-up
18 hours
Authors
Loading...
May explain Ang II effects on vascular insulin signaling in animals; leaves open translation to ARB metabolic benefits in humans.
Does Angiotensin II induce IRS-1 degradation and impair insulin signaling in vascular smooth muscle cells?
Angiotensin II impairs insulin signaling in vascular smooth muscle cells by promoting ROS-dependent IRS-1 degradation, providing a molecular mechanism for the beneficial metabolic effects of angiotensin receptor blockers.
Taniyama et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: